Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

26.03.15	EBS, REGN Get FDA Nod, OVAS To Deliver, Recro Recuperates, Watch Out For ZSAN (RTTNews)
23.03.15	Eli Lilly & Boehringer Announce Availability Of Glyxambi Tablets In U.S. (RTTNews)
23.03.15	Pfizer & Eli Lilly To Resume Tanezumab Phase 3 Program - Quick Facts (RTTNews)
20.03.15	Eli Lilly & Innovent Biologics Announce Collaboration - Quick Facts (RTTNews)
19.03.15	Eli Lilly & Hanmi Collaborate To Develop Hanmi's Tyrosine Kinase Inhibitor (RTTNews)
06.03.15	German Appeal Court Says Generic Product Would Not Infringe Eli Lilly's Alimta (RTTNews)
03.03.15	Denovo Biopharma Licenses Pomaglumetad From Eli Lilly - Quick Facts (RTTNews)
24.02.15	BMY, VRX Open Wallet, LLY Does It Again, RIGL Gets A Regal Touch, TRIB Is Back (RTTNews)
23.02.15	Lilly Delays Regulatory Submission On Basal Insulin Peglispro - Quick Facts (RTTNews)
23.02.15	Lilly: Baricitinib Superior To Placebo In Reducing Rheumatoid Arthritis Activity (RTTNews)
20.02.15	Mark Your Calendar For TCON, XLRN, Xenon Lights Up, MACK Gets Going (RTTNews)
19.02.15	Eli Lilly Extends Phase 3 Trial Of Evacetrapib By Approx. Six Months (RTTNews)
02.02.15	Lilly : FDA OKs First-in-class Glyxambi Tablets For Adults With Type 2 Diabetes (RTTNews)
30.01.15	Eli Lilly Q4 Adj. Profit Beats View, Lowers 2015 Revenue Guidance (RTTNews)
30.01.15	Eli Lilly Q4 Profit Tops Estimates - Quick Facts (RTTNews)
14.01.15	LLY Collaborates With BMY And MRK, CLTX On Watchlist, ZLTQ Continues To Grow (RTTNews)
13.01.15	Bristol-Myers, Lilly To Evaluate Opdivo In Combination With Galunisertib (RTTNews)
13.01.15	Merck, Eli Lilly In Oncology Clinical Trial Collaboration - Quick Facts (RTTNews)
01.01.15	Novartis Closes Sale Of Animal Health Business To Eli Lilly For $5.4 Billion (RTTNews)
19.12.14	Eli Lilly, Adocia Team Up On Developing Ultra-rapid Insulin BioChaperone Lispro (RTTNews)
16.12.14	FDA Okays Lilly's CYRAMZA To Treat Non-Small Cell Lung Cancer (RTTNews)
13.12.14	Lilly's Oncology Drug Cyramza Scores FDA Approval For Another Indication (RTTNews)
09.12.14	Eli Lilly, Incyte Say Arthritis Drug Baricitinib Meets Primary Endpoint (RTTNews)
08.12.14	Anthem, Eli Lilly, HealthCore Form Research Collaboration - Quick Facts (RTTNews)
02.12.14	Zosano & Eli Lilly To Develop ZP-PTH For Treatment Of Osteoporosis Patients (RTTNews)
01.12.14	Eli Lilly, AstraZeneca Enroll First Patient Into AMARANTH - Quick Facts (RTTNews)
10.11.14	Lilly Announces U.S. Availability Of Trulicity (RTTNews)
05.11.14	FDA Oks Cyramza Combined With Paclitaxel For Gastric Cancer Prior Chemotherapy (RTTNews)
29.10.14	Lilly, Boehringer Ingelheim Revise Diabetes Alliance In Certain Countries (RTTNews)
28.10.14	Judge Slashes Penalty In Case Against Eli Lilly, Takeda On Diabetes Drug Actos (RTTNews)
27.10.14	Virbac To Buy Veterinary Assets From Eli Lilly In U.S. - Quick Facts (RTTNews)
23.10.14	Lilly Q3 Profit Falls 58% (RTTNews)
23.10.14	Lilly Q3 Non-GAAP EPS Misses View; Revises Reported EPS View - Quick Facts (RTTNews)
21.10.14	FDA Accepts Lilly's NDA Filing For Empagliflozin/metformin Combination (RTTNews)
16.10.14	Lilly To Realign Puerto Rico Manufacturing Operations - Quick Facts (RTTNews)
08.10.14	Novartis Unveils Executive Committee Changes Post Portfolio Transactions (RTTNews)
03.10.14	EU Approves Eli Lilly's Acquisition Of Novartis Animal Health Business (RTTNews)
03.10.14	EU Okays Acquisition Of Novartis Animal Health Business By Lilly (RTTNews)
02.10.14	Lilly To Record Charge In Q3 As It Discontinue Development Of Tabalumab (RTTNews)
19.09.14	Lilly Says FDA Approves Type 2 Diabetes Drug Trulicity (RTTNews)
18.09.14	Lilly's Phase III Trial Of Cyramza With Paclitaxel Meets Endpoints (RTTNews)
16.09.14	AstraZeneca, Lilly To Jointly Develop AZD3293 For Alzheimer's Disease - Update (RTTNews)
16.09.14	AstraZeneca, Lilly Reach Deal On BACE Inhibitor AZD3293 For Alzheimer's Disease (RTTNews)
12.09.14	Lilly's Phase III Trial With Cyramza Meets Primary Endpoint - Quick Facts (RTTNews)
08.09.14	Gilead: AMBITION Study Of Ambrisentan/Tadalafil Achieves Primary Endpoint (RTTNews)
04.09.14	Lilly's BIL Showed HbA1c Superiority Against Lantus In Phase III Trials (RTTNews)
26.08.14	Lilly, Boehringer Say Jardiance Tablets For Type 2 Diabetes Available In U.S. (RTTNews)
21.08.14	Lilly Says Ixekizumab Superior To Etanercept/Placebo In Phase 3 Psoriasis Study (RTTNews)
21.08.14	Lilly:Ixekizumab Superior To Etanercept &Placebo In Late-stage Psoriasis Studies (RTTNews)
19.08.14	FDA Grants Tentative Approval For Lilly And Boehringer Ingelheim's Basaglar (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

07:36		Novartis-Aktie: Novartis will bei Krebskongressen zahlreiche Studiendaten präsentieren
22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester
22.11.24		Deutsche Bank AG: Novartis-Aktie erhält Hold
22.11.24		Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester
22.11.24		Optimismus in Europa: So entwickelt sich der Euro STOXX 50 am Freitagnachmittag

07:36

Novartis-Aktie: Novartis will bei Krebskongressen zahlreiche Studiendaten präsentieren

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Deutsche Bank AG: Novartis-Aktie erhält Hold